132 related articles for article (PubMed ID: 8696447)
1. The plasma turnover of transfused antithrombin concentrate in patients with acquired antithrombin deficiency.
Harper PL; Park GR; Carrell RW
Transfus Med; 1996 Mar; 6(1):45-50. PubMed ID: 8696447
[TBL] [Abstract][Full Text] [Related]
2. Clinical experience with antithrombin III concentrate in treatment of congenital and acquired deficiency of antithrombin. The Antithrombin III Study Group.
Schwartz RS; Bauer KA; Rosenberg RD; Kavanaugh EJ; Davies DC; Bogdanoff DA
Am J Med; 1989 Sep; 87(3B):53S-60S. PubMed ID: 2679072
[TBL] [Abstract][Full Text] [Related]
3. Antithrombin III transfusion in patients with hepatic cirrhosis.
Schipper HG; ten Cate JW
Br J Haematol; 1982 Sep; 52(1):25-33. PubMed ID: 7115627
[TBL] [Abstract][Full Text] [Related]
4. Elimination of antithrombin III concentrate in healthy pregnant and preeclamptic women with an acquired antithrombin III deficiency.
Weiner CP; Herrig JE; Pelzer GD; Heilskov J
Thromb Res; 1990 May; 58(4):395-401. PubMed ID: 2353344
[TBL] [Abstract][Full Text] [Related]
5. Hereditary and acquired antithrombin deficiency: epidemiology, pathogenesis and treatment options.
Maclean PS; Tait RC
Drugs; 2007; 67(10):1429-40. PubMed ID: 17600391
[TBL] [Abstract][Full Text] [Related]
6. Effective prophylaxis of thrombosis by antithrombin III concentrate in a pregnant woman with congenital antithrombin III deficiency: relations between plasma antithrombin III activity and the plasma levels of hemostatic molecular markers.
Inomoto T; Takamoto M; Tamura R; Maegawa M; Kamada M; Takayanagi M
Haemostasis; 1991; 21(3):147-54. PubMed ID: 1773985
[TBL] [Abstract][Full Text] [Related]
7. Treatment of consumption coagulopathy with antithrombin concentrate in children with acquired antithrombin deficiency--a feasibility pilot study.
Kreuz WD; Schneider W; Nowak-Göttl U
Eur J Pediatr; 1999 Dec; 158 Suppl 3():S187-91. PubMed ID: 10650867
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic antithrombin III administration during pregnancy immediately reduces the thrombin hyperactivity of congenital antithrombin III deficiency by forming thrombin-antithrombin III complexes.
Kario K; Matsuo T; Kodama K; Matsuo M
Thromb Res; 1992 Jun; 66(5):509-15. PubMed ID: 1523607
[TBL] [Abstract][Full Text] [Related]
9. Acquired antithrombin III deficiency: laboratory diagnosis, incidence, clinical implications, and treatment with antithrombin III concentrate.
Büller HR; ten Cate JW
Am J Med; 1989 Sep; 87(3B):44S-48S. PubMed ID: 2679070
[TBL] [Abstract][Full Text] [Related]
10. [Management with antithrombin III concentrate in a pregnant woman with hereditary antithrombin III deficiency].
Higuchi M; Konya H; Tanaka H; Masuda H; Nishida Y; Koyama T; Suehiro A; Kakishita E; Ishita K
Rinsho Ketsueki; 1990 Sep; 31(9):1544-7. PubMed ID: 2246830
[TBL] [Abstract][Full Text] [Related]
11. The transient increase of plasma thrombin-antithrombin III (TAT) complex levels in patients with congenital antithrombin III deficiency during antithrombin III administration is due to extraction of thrombin from fibrin.
Kario K; Matsuo T; Kabayashi H; Matsuo M; Yamamoto K
Thromb Res; 1991 Aug; 63(4):469-72. PubMed ID: 1755000
[No Abstract] [Full Text] [Related]
12. Antithrombin III concentrate to treat heparin resistance in patients undergoing cardiac surgery.
Lemmer JH; Despotis GJ
J Thorac Cardiovasc Surg; 2002 Feb; 123(2):213-7. PubMed ID: 11828278
[TBL] [Abstract][Full Text] [Related]
13. Treatment of congenital antithrombin III deficiency with concentrates.
Mannucci PM; Boyer C; Wolf M; Tripodi A; Larrieu MJ
Br J Haematol; 1982 Mar; 50(3):531-5. PubMed ID: 7066204
[TBL] [Abstract][Full Text] [Related]
14. Initial experience with recombinant antithrombin to treat antithrombin deficiency in patients on extracorporeal membrane oxygenation.
Niimi KS; Fanning JJ
J Extra Corpor Technol; 2014 Mar; 46(1):84-90. PubMed ID: 24779124
[TBL] [Abstract][Full Text] [Related]
15. Observations during the treatment of antithrombin-III deficient women with heparin and antithrombin concentrate during pregnancy, parturition, and abortion.
Brandt P
Thromb Res; 1981 Apr 1-15; 22(1-2):15-24. PubMed ID: 7292437
[TBL] [Abstract][Full Text] [Related]
16. Transfusion studies in patients with familial antithrombin III (ATIII) deficiency: half-disappearance time of infused ATIII and influence of such infusion on platelet life-span.
Winter JH; Fenech A; Bennett B; Douglas AS
Br J Haematol; 1981 Nov; 49(3):449-53. PubMed ID: 7295588
[TBL] [Abstract][Full Text] [Related]
17. Treatment with AT III concentrates in hereditary and acquired AT III deficiency.
Gromnica-Ihle E; Ziemer S
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):307-13. PubMed ID: 2465221
[TBL] [Abstract][Full Text] [Related]
18. [Anti-coagulant therapy--antithrombin III].
Tsuji H
Rinsho Ketsueki; 1990 Jun; 31(6):750-5. PubMed ID: 2214165
[TBL] [Abstract][Full Text] [Related]
19. [Experiences with the substitution of antithrombin III concentrates in congenital and acquired deficiency disorders].
Schramm W
Behring Inst Mitt; 1983 Aug; (73):66-78. PubMed ID: 6332613
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the safety, recovery, half-life, and clinical efficacy of antithrombin III (human) in patients with hereditary antithrombin III deficiency. Cooperative Study Group.
Menache D; O'Malley JP; Schorr JB; Wagner B; Williams C; Alving BM; Ballard JO; Goodnight SH; Hathaway WE; Hultin MB
Blood; 1990 Jan; 75(1):33-9. PubMed ID: 2403821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
